Search Results - "Casciarri, I"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy by Zeneroli, M L, Baraldi, M, Ventura, E, Vezzelli, C, Tofanetti, O, Germini, M, Casciarri, I

    Published in Life sciences (1973) (1991)
    “…The binding characteristics of gamma-aminobutyric acid-A (GABA-A) receptors and the kinetic characteristics of the target enzyme of GABA synthesis in nerve…”
    Get more information
    Journal Article
  2. 2

    A clinical assessment of the potential for pharmacological interaction between nimesulide and digoxin in patients with heart failure by BAGGIO, E, MARAFFI, F, MONTALTO, C, NAVA, M. L, TORTI, L, CASCIARRI, I

    Published in Drugs (Basel) (1993)
    “…The potential interaction between nimesulide, a nonsteroidal anti-inflammatory drug, and digoxin was studied in 9 patients [6 males, 3 females; mean age 67…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    Opiate receptors and beta-endorphin levels in brain areas of dogs with portal-systemic encephalopathy by Zeneroli, M L, Ventura, E, Pinelli, G, Casciarri, I, Germini, M, Cavalletti, E, Tofanetti, O, Baraldi, M

    Published in Journal of hepatology (1985)
    “…Clinical observation has indicated a supersensitivity to morphine in patients with hepatic encephalopathy. With the aim of clarifying the issue, radioreceptor…”
    Get more information
    Journal Article
  4. 4

    Efficacy of glutathione for treatment of fascioliasis. An investigation in the experimentally infested rat by Maffei Facino, R, Carini, M, Aldini, G, Ceserani, R, Casciarri, I, Cavalletti, E, Verderio, L

    Published in Arzneimittel-Forschung (01-04-1993)
    “…Liver fluke infection (Fasciola hepatica) depresses the drug-metabolizing capacity of the hepatic mixed function oxidase (MFO) and glucuronosyltransferase (GT)…”
    Get more information
    Journal Article
  5. 5

    Experimental studies on pharmacology, metabolism and toxicology with tiadenol-disulfoxide. Dissociation of lipid lowering effects and the induction of peroxisomal and microsomal drug-metabolizing enzymes by Maffei Facino, R, Carini, M, Tofanetti, O, Casciarri, I, Longoni, E

    Published in Arzneimittel-Forschung (01-06-1987)
    “…The hypolipidemic activity of tiadenol-disulfoxide, the major metabolite of 1,10-bis(hydroxyethylthio)decane (tiadenol, Eulip) in man and in the rat was…”
    Get more information
    Journal Article
  6. 6

    Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat by Maffei Facino, R, Carini, M, Genchi, C, Tofanetti, O, Casciarri, I, Bedoschi, D

    Published in Arzneimittel-Forschung (01-04-1990)
    “…The antihepatotoxic properties of uridine-diphosphoglucose (UDPG, Toxepasi) have been evaluated in a well-established model of liver damage, the liver fluke…”
    Get more information
    Journal Article
  7. 7

    Bacterial toxins and glucagon in liver cAMP regulation: a physiopathological role in liver diseases? by Scevola, D, Barbarini, G, Marone, P, Casciarri, I, Bernardi, R, Magliulo, E

    “…Alterations of the specific enzymes located in the cell membranes might promote changes of the cyclic nucleotides ratio which is regulatory in growth…”
    Get more information
    Journal Article
  8. 8

    Participation of lipid peroxidation in the loss of hepatic drug-metabolizing activities in experimental fascioliasis in the rat by Maffei Facino, R, Carini, M, Genchi, C, Tofanetti, O, Casciarri, I

    Published in Pharmacological research (01-09-1989)
    “…Fascioliasis causes a dramatic decrease in drug-metabolizing ability of the hepatic monooxygenase (MFO) and glucuronosyltransferase (GT) enzyme systems in the…”
    Get more information
    Journal Article
  9. 9
  10. 10